AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $8,445 | +19.6% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $7,060 | +37.1% | 500 | 0.0% | 0.00% | – |
| Q3 2023 | $5,150 | -37.5% | 500 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $8,240 | +79.9% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $4,580 | +27.9% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $3,580 | +79.0% | 500 | +25.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 400 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 400 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 400 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 400 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 400 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -25.0% | 400 | -50.0% | 0.00% | -100.0% |
| Q3 2020 | $4,000 | -33.3% | 800 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | +100.0% | 800 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | +50.0% | 800 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 800 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 800 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -95.1% | 800 | -91.4% | 0.00% | -100.0% |
| Q3 2018 | $41,000 | -28.1% | 9,300 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $57,000 | -16.2% | 9,300 | 0.0% | 0.01% | -18.2% |
| Q1 2018 | $68,000 | -10.5% | 9,300 | 0.0% | 0.01% | -8.3% |
| Q4 2017 | $76,000 | -22.4% | 9,300 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $98,000 | -4.9% | 9,300 | 0.0% | 0.02% | -5.9% |
| Q2 2017 | $103,000 | +14.4% | 9,300 | 0.0% | 0.02% | +13.3% |
| Q1 2017 | $90,000 | – | 9,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,416,326 | $34,118,517 | 12.83% |
| Knoll Capital Management, LLC | 600,000 | $8,472,000 | 7.02% |
| Tri Locum Partners LP | 839,933 | $11,859,854 | 5.42% |
| Vivo Capital, LLC | 4,096,428 | $57,841,563 | 4.74% |
| GENDELL JEFFREY L | 5,615,350 | $79,288,742 | 4.31% |
| Ally Bridge Group (NY) LLC | 347,036 | $4,900,148 | 2.92% |
| Checkpoint Capital L.P. | 325,000 | $4,589,000 | 2.78% |
| MPM BioImpact LLC | 664,986 | $9,389,602 | 2.20% |
| Samsara BioCapital, LLC | 967,527 | $13,661,481 | 2.12% |
| RTW INVESTMENTS, LP | 6,947,918 | $98,104,602 | 1.53% |